Seahorse Bioscience
{{Short description|Company that develops bioenergetics analytical instruments}}
{{promotional|date=April 2018}}
{{Use mdy dates|date=December 2024}}
{{Infobox company
| name = Seahorse Bioscience
| logo =
| type = Private
| foundation = 2001
| location = North Billerica, Massachusetts
| key_people = Jay Teich
| industry = Bioscience
| products =
| revenue =
| num_employees =
| parent =
| homepage = http://www.seahorsebio.com/
}}
Seahorse Bioscience is a private company that develops and manufactures cellular bioenergetics analytical instruments. Seahorse also manufactures consumable labware products, and consumables for measuring cell metabolism.{{cite web |url=http://www.masshightech.com/stories/2012/05/21/daily19-Seahorse-Bioscience-raises-94M.html |title=Seahorse Bioscience raises $9.4M |author=Lori Valigra |date=May 22, 2012|publisher= MHT|access-date=January 18, 2013}}{{cite web |url=http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=1716714 |archive-url=https://web.archive.org/web/20130730194632/http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=1716714 |url-status=dead |archive-date=July 30, 2013 |title=Company Overview of Seahorse Bioscience, Inc. |author= |date=January 18, 2013|publisher= Businessweek.com|access-date=January 18, 2013}}{{cite web |url=http://www.bizjournals.com/boston/news/2012/05/22/seahorse-bioscience.html |title=Seahorse Bioscience raises $9.4M for biotech labware |author=Lori Valigra |date=May 22, 2012|publisher= Boston Business Journal|access-date=January 18, 2013}} The company was formerly known as Thermogenic Imaging.{{cite web |url=http://www.reportlinker.com/p0669080-summary/Seahorse-Bioscience-Inc-formerly-Thermogenic-Imaging-Mergers-Acquisitions-M-A-Partnerships-Alliances-and-Investment-Report.html |title=Seahorse Bioscience, Inc. (formerly Thermogenic Imaging) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report |author= MarketLine |date=September 2011 |publisher= ReportLinker|access-date=January 18, 2013}} Recognized for developing novel, leading-edge cellular bioenergetic technologies, the company is best known for developing the XF Extracellular Flux Analyzer.{{cite web |url=http://www.bucher.ch/en/products/Seahorse_Bioscience.html |title=Seahorse Bioscience Inc. |author= |date= |publisher= BusherBiotec|access-date=January 18, 2013}}{{cite web |url=http://meshpress.com/seahorse-bioscience-achieves-milestone-in-instrument-shipments/1214179.html |title=Seahorse Bioscience Achieves Milestone in Instrument Shipments |author= |date=October 10, 2012 |publisher= MeshPress|access-date=January 18, 2013}}
The first in vitro metabolic measurement, XF technology non-invasively profiles the metabolic activity of cells in minutes, offering scientists a physiologic cell-based assay for the determination of basal oxygen consumption, glycolysis rates, ATP production, and respiratory capacity in a single experiment to assess mitochondrial dysfunction.
Company President and CEO, Jay Teich founded the company in 2001 along with Andy Neilson and Jim Orrell.{{cite web |url= |title=Snapshot: Seahorse Bioscience Inc. |author=LexisNexis |date=November 23, 2012 |publisher= LexisNexis|access-date=}}{{cite web |url=http://www.insideview.com/directory/seahorse-bioscience-inc |title=Seahorse Bioscience, Inc. |author= |date= |publisher= InsideView|access-date=January 18, 2013}} Seahorse Bioscience is headquartered in North Billerica, Massachusetts, with its manufacturing facility in Chicopee, Massachusetts, and international offices in Shanghai, China and Copenhagen, Denmark.{{cite web |url=http://www.seahorsebio.com/ |title=Seahorse Bioscience |author= |date=|publisher= Seahorse Bioscience |access-date=January 18, 2013}} In early 2016, Seahorse Bioscience was acquired by Agilent Technologies.{{cite web |title=Agilent |url=http://www.agilent.com/en-us/promotions/xftechnologyoverview |access-date=June 17, 2023 |archive-url=https://web.archive.org/web/20161220002958/http://www.agilent.com/en-us/promotions/xftechnologyoverview |archive-date=December 20, 2016 |language=en}}
History
Seahorse Bioscience introduced extracellular flux technology to the life sciences market in 2006. XF instruments measure cellular bioenergies in real time, in a microplate, and are used for scientific research, as well as drug discovery and development.
Seahorse Bioscience bought BioProcessors Corp in 2009.{{cite web |url= |title=Target: BioProcessors Corp. Buyer: Seahorse Bioscience, Inc. |author=Mergerstat M&A Database |date=November 23, 2012 |publisher= FactSet Mergerstat, LLC|access-date= }} BioProcessors Corp manufactured systems for optimizing drug manufacturing.
XF Analyzers are capable of measuring the two major energy producing pathways of the cell simultaneously, mitochondrial respiration and glycolysis, allowing scientists to get the most physiologically relevant bioenergetic assay available, resulting in a better overall view of metabolism. XF technology also measures fatty acid oxidation, and metabolism of glucose and amino acids for kinetic metabolic information. Research on obesity, diabetes, cancer, and neurodegenerative diseases use this technology.{{cite web |url=http://www.xconomy.com/boston/2010/02/23/seahorse-bioscience-bags-5m/ |title=Seahorse Bioscience Bags $5M |author=Howard Lovy |date=February 23, 2010 |publisher= Xconomy|access-date=January 18, 2013}}
Seahorse Bioscience raised $9.4 million to use for research and development, and company growth in 2012. The European Union awarded the company a $3 million grant in 2012 for implementing programs to train young researchers.{{cite web |url=http://www.masshightech.com/stories/2012/05/28/daily47-Seahorse-Bioscience-to-share-3M-3-year-grant.html
|title=Seahorse Bioscience to share $3M, 3-year grant |author=Don Seiffert |date=June 1, 2012 |publisher= BusinessJournal|access-date=January 18, 2013}}
The company had 150 employees in May 2012.
Prior investors in Seahorse Bioscience include HML Venture Partners, Commonwealth Capital Ventures, FLIR Systems Inc., New Science Ventures, and Healthcare Ventures.
Products
Seahorse Bioscience sells instruments and consumables. The XF Extracellular Flux Analyzer is the best-selling instrument. Consumables include Flux Paks, Microplates, and Stress Kits. The Flux Analyzer can measure extracellular acidification rate (ECAR) and oxygen consumption of tissue samples. Aliquoting different cell metabolism inhibitors can also measure metrics such as glycolytic and aerobic capacity.{{Cite web|title=Glycolysis Stress Test kit, Seahorse Glycolysis Stress Test Kit {{!}} Agilent|url=https://www.agilent.com/en/product/cell-analysis/real-time-cell-metabolic-analysis/xf-assay-kits-reagents-cell-assay-media/seahorse-xf-glycolysis-stress-test-kit-740886?gclid=Cj0KCQiAzMGNBhCyARIsANpUkzOAtMDlZijLoW6c4CimUvlrTDRlD0ydxhykiH2effjuSIReER3geWsaAq-HEALw_wcB&gclsrc=aw.ds|access-date=December 8, 2021|website=www.agilent.com}}
The XF Palmitate-BSA FAO Reagent is a solution absorbed by cells. This product eliminates the need for radioactivity in fatty acid oxidation.{{cite web |url=http://www.biospace.com/News/seahorse-bioscience-launches-reagent-to-make/265135 |title=Seahorse Bioscience Launches Reagent to Make Functional Fatty Acid Oxidation (FAO) Assays Easy |author= |date=June 26, 2012 |publisher= Seahorse Bioscience, Inc|access-date=January 18, 2013}}
Recognition
Seahorse Bioscience received The European Association for the Study of Obesity (EASO) poster award in 2008.{{cite web |url=http://www.devicespace.com/News/seahorse-bioscience-receives-poster-award-from-the/103830 |title=Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity |author= |date=July 18, 2008 |publisher= Device Space|access-date=January 18, 2013}}
“The Scientist” awarded Seahorse Bioscience's XF96 Analyzer a Top Ten Innovation for 2009.{{cite web |url=http://www.devicespace.com/company_profile.aspx?CompanyId=1006294 |title=Seahorse Bioscience |author= |date= |publisher= Device Space|access-date=January 18, 2013}} It also won the Best New Product award at the 2009 Molecular Medicine Conference.{{cite web |url=http://www.devicespace.com/News/seahorse-bioscience-xf96-extracellular-flux/130547
|title=Seahorse Bioscience XF96 Extracellular Flux Analyzer Wins Best New Product Award for DRUG DISCOVERY at 2009 Molecular Medicine Conference |author=BioSpace.com
|date=March 13, 2009 |publisher= Device Space|access-date=January 18, 2013}}
Inc.com ranked Seahorse Bioscience on the 2011 Inc. 5000 List, and also the 2012 Inc.5000 List.{{cite web |url=http://www.inc.com/inc5000/list/2012/ |title=Inc.5000 |author= |date= |publisher= Inc.|access-date=January 18, 2013}} In 2012 the company ranked #119 in all Health related companies and #47 for all companies in the Boston area.{{cite web |url=http://www.inc.com/inc5000/list/metro/boston|title=Top Companies in the Boston Metro Area on the 2012 Inc. 5000 |author= |date= |publisher= Inc.|access-date=January 18, 2013}}{{cite web |url=http://www.inc.com/inc5000/list/2012/industry/health |title=Top Health Companies on the 2012 Inc. 5000 |author= |date= |publisher= Inc.|access-date=January 18, 2013}}